Evrofarma SA Cash Flow Conversion Efficiency
Evrofarma SA cash flow conversion efficiency. Based on the latest financial reports, Evrofarma SA (EVROF) has a cash flow conversion efficiency ratio of 0.108x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.52 Million ≈ $1.77 Million USD) by net assets (€14.03 Million ≈ $16.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Evrofarma SA (2014–2022)
Cash flow conversion efficiency of Evrofarma SA from 2014 to 2022. This chart illustrates how Evrofarma SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Evrofarma SA stock price for real-time trading data and today's change.
Evrofarma SA Cash Flow Conversion Ratio Explained
Evrofarma SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Evrofarma SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evrofarma SA ranked by their cash flow conversion efficiency. Also see EVROF market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Company K Partners Limited
KQ:307930
|
-0.077x |
|
Decidr Ai Industries Ltd
AU:DAI
|
-0.082x |
|
Hannan Metals Ltd
V:HAN
|
-0.019x |
|
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV
|
-0.096x |
|
Consolidated Construction Consortium Limited
NSE:CCCL
|
-0.260x |
|
Suprema ID Inc
KQ:317770
|
0.014x |
|
TsannKuen (China) Enterprise Co. Ltd
SHE:200512
|
-0.016x |
|
Pratama Widya Tbk Pt
JK:PTPW
|
0.027x |
Annual Cash Flow Conversion Efficiency for Evrofarma SA (2014–2022)
The table below shows the annual cash flow conversion efficiency of Evrofarma SA from 2014 to 2022. Review EVROF free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €14.03 Million ≈ $16.40 Million |
€2.44 Million ≈ $2.85 Million |
0.174x | +372.38% |
| 2021-12-31 | €12.61 Million ≈ $14.74 Million |
€-805.00K ≈ $-941.13K |
-0.064x | -156.73% |
| 2020-12-31 | €12.95 Million ≈ $15.14 Million |
€1.46 Million ≈ $1.70 Million |
0.113x | -24.84% |
| 2019-12-31 | €11.87 Million ≈ $13.88 Million |
€1.78 Million ≈ $2.08 Million |
0.150x | -23.84% |
| 2018-12-31 | €11.65 Million ≈ $13.63 Million |
€2.29 Million ≈ $2.68 Million |
0.197x | -32.08% |
| 2017-12-31 | €10.73 Million ≈ $12.54 Million |
€3.11 Million ≈ $3.63 Million |
0.290x | +173.21% |
| 2016-12-31 | €10.20 Million ≈ $11.93 Million |
€1.08 Million ≈ $1.26 Million |
0.106x | -25.34% |
| 2015-12-31 | €9.79 Million ≈ $11.45 Million |
€1.39 Million ≈ $1.63 Million |
0.142x | +51.87% |
| 2014-12-31 | €9.27 Million ≈ $10.83 Million |
€866.00K ≈ $1.01 Million |
0.093x | -- |
About Evrofarma SA
Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.